TrialThe Journal of antimicrobial chemotherapy2019

Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART.

Anne Derache et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.